Get the Stockscreener App
18.62
9.53%
1.62
After Hours:
18.90
0.28
+1.50%
Kala Bio Inc stock is traded at $18.62, with a volume of 547.59K.
It is up +9.53% in the last 24 hours and up +150.27% over the past month.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
See More
Previous Close:
$17.00
Open:
$17
24h Volume:
547.59K
Relative Volume:
3.16
Market Cap:
$130.73M
Revenue:
$5.75M
Net Income/Loss:
$-38.96M
P/E Ratio:
-1.4932
EPS:
-12.47
Net Cash Flow:
$-32.63M
1W Performance:
+27.97%
1M Performance:
+150.27%
6M Performance:
+167.91%
1Y Performance:
+212.94%
1-Day Range:
$16.90
$18.89
1-Week Range:
$13.13
$18.89
52-Week Range:
$2.92
$18.89
Kala Bio Inc Stock (KALA) Company Profile
Name
Kala Bio Inc
Sector
Industry
Phone
781-996-5252
Address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
18.62 | 107.21M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Mizuho | Outperform |
| Jul-11-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-30-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-14-20 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-20 | Initiated | Northland Capital | Outperform |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| May-27-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-17-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-14-19 | Initiated | Jefferies | Buy |
View All
Kala Bio Inc Stock (KALA) Latest News
Brokerages Set KALA BIO, Inc. (NASDAQ:KALA) Price Target at $17.25 - MarketBeat
How high can KALA BIO Inc. stock goTrade Volume Report & Advanced Swing Trade Entry Plans - Newser
Custom strategy builders for tracking KALA BIO Inc.Share Buyback & Safe Entry Point Alerts - Newser
Has KALA BIO Inc. formed a bullish divergence2025 Retail Activity & Verified Entry Point Signals - Newser
Analyzing net buyer seller activity in KALA BIO Inc.July 2025 Market Mood & Weekly Breakout Stock Alerts - Newser
Using data tools to time your KALA BIO Inc. exitJuly 2025 Rallies & Long-Term Investment Growth Plans - Newser
Detecting price anomalies in KALA BIO Inc. with AI2025 Investor Takeaways & Target Return Focused Picks - Newser
What does recent volatility data suggest for KALA BIO Inc.July 2025 Pullbacks & High Conviction Buy Zone Alerts - Newser
How to monitor KALA BIO Inc. with trend dashboardsJuly 2025 EndofMonth & Reliable Price Breakout Alerts - Newser
How to read the order book for KALA BIO Inc.Quarterly Trade Summary & Precise Swing Trade Alerts - Newser
Risk adjusted return profile for KALA BIO Inc. analyzedJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser
How moving averages guide KALA BIO Inc. tradingJuly 2025 Review & Technical Buy Zone Confirmation - Newser
What makes KALA BIO Inc. stock price move sharplyJuly 2025 Short Interest & AI Powered Market Entry Ideas - Newser
Real time pattern detection on KALA BIO Inc. stock2025 Top Decliners & Technical Buy Zone Confirmations - Newser
Tools to monitor KALA BIO Inc. recovery probabilityWeekly Trend Recap & Verified Stock Trade Ideas - Newser
What momentum shifts mean for KALA BIO Inc.Quarterly Profit Summary & Precise Buy Zone Identification - Newser
Can machine learning forecast KALA BIO Inc. recoveryMarket Volume Report & Capital Efficient Trade Techniques - Newser
Oppenheimer Adjusts Price Target on KALA BIO to $33 From $15, Maintains Outperform Rating - MarketScreener
KALA Stock: Oppenheimer Raises Price Target Amid Outperform Rati - GuruFocus
How to manage a losing position in KALA BIO Inc.Portfolio Value Report & Expert Approved Momentum Ideas - Newser
KALA BIO, Inc. (NASDAQ:KALA) Receives $17.25 Consensus Price Target from Brokerages - Defense World
Can KALA BIO Inc. rally from current levelsJuly 2025 Final Week & High Yield Stock Recommendations - Newser
Statistical indicators supporting KALA BIO Inc.’s strengthJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - Newser
Q3 Earnings Forecast for KALA BIO Issued By Lifesci Capital - MarketBeat
KALA BIO (NASDAQ:KALA) Now Covered by Mizuho - MarketBeat
Using Python tools to backtest KALA BIO Inc. strategiesMarket Activity Summary & Smart Allocation Stock Tips - Newser
Will KALA BIO Inc. continue its uptrendWall Street Watch & Weekly Consistent Profit Watchlists - Newser
Should you hold or exit KALA BIO Inc. nowEarnings Miss & Real-Time Volume Trigger Notifications - Newser
Smart tools for monitoring KALA BIO Inc.’s price action - Newser
Signal strength of KALA BIO Inc. stock in tech scannersMarket Trend Report & Trade Opportunity Analysis - Newser
KALA BIO (NASDAQ:KALA) Raised to Strong-Buy at Lifesci Capital - MarketBeat
Is KALA BIO Inc. a candidate for recovery playEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - Newser
KALA BIO Inc.’s volatility index tracking explained2025 Year in Review & Fast Gain Stock Trading Tips - Newser
What’s next for KALA BIO Inc. stock priceWeekly Gains Report & Risk Controlled Swing Alerts - Newser
What MACD signals say about KALA BIO Inc.Buy Signal & Reliable Volume Spike Trade Alerts - Newser
Kala Bio Inc Stock (KALA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):